https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine
Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine
Updated 10 December 2020
Regulation 174 Information for UK healthcare professionals
This medicinal product does not have a UK marketing authorisation but has been given
authorisation for temporary supply by the UK Department of Health and Social Care and the
Medicines & Healthcare products Regulatory Agency for active immunization to prevent
COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 16 years of age and over.
As with any new medicine in the UK, this product will be closely monitored to allow quick
identification of new safety information. Healthcare professionals are asked to report any
suspected adverse reactions. See section 4.8 for how to report adverse reactions.